TP53 and cancer: The KEGG analysis revealed that the DEGs were significantly enriched in several common cancer-related pathways, such as CRC, the p53 signaling pathway, Hippo signaling pathway, oxidative phosphorylation, ErbB signaling pathway, nucleotide metabolism, and pyrimidine metabolism (Figure 3G; Supplementary Table 6).